SPDR S&P Biotech ETF Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (68)

Latest Posts

About This Stock More About This Stock
Small Cap Biotechs Perk Up On Dealmaking
Article By: Rod Raynovich
Saturday, August 6, 2022 9:38 PM EDT
With M&A picking up we would think smaller deals make sense for large cap biopharma to expand pipelines and complement technology.
In this article: PFE, AMGN, XBI, CCXI, GBT Also: MRNA, CRSP
Broad Market Rallies Despite Currency Headwinds
Article By: Rod Raynovich
Wednesday, July 20, 2022 4:45 AM EDT
HealthCare and Biotech shares have been strong over the past 30 days as investors have sought trades away from macro and earnings concerns. In times of volatility portfolio strategists may re-balance positions toward defensive healthcare stocks.
In this article: JNJ, UNH, IHI, XBI, XLV
Small Cap Biotech Stocks Are Trending Well
Article By: Rod Raynovich
Monday, July 18, 2022 4:14 AM EDT
Despite a little weakness last week, small cap biotechs are trending well for traders. For investors entering the trade on July 5 all of our. focus stocks are up except ChemoCentryx.
5 ETFs Riding High On The Biotech Comeback
Article By: Sweta Killa
Saturday, July 9, 2022 10:57 PM EDT
The high-growth biotech segment has borne the maximum brunt of the broader market sell-off.
In this article: XBI, BBC, BBP, SBIO, CNCR
This Biotech Looks Good With Increased M&A Activity
Article By: InvestorsAlley
Friday, May 20, 2022 3:49 AM EDT
Fierce Biotech backs this up: “Biopharmas have $1.7 trillion to spend on deals this year, and big players like Novartis, Pfizer and Merck & Co. have made it pretty clear they’re on the hunt for acquisitions.
In this article: ACAD, EXEL, XBI

Latest Tweets for $XBI

No tweets yet!



Biotech Review - Waiting For A Reset
Dick Kaplan 2/23/2021 5:25:18 PM

Good analysis. However, you missed the hourly chart. The biotech correction on the daily is possibly over. Why? Because the daily averages crossed and point upward on hourly chart. Talking daily, the current candle is perfectly sitting on the trend line support and between the 10sma and 30 ema with $XBI on a intact uptrend. So all stars seem aligned for the XBI to resume in a upward channel.

Leadership (Bio-Tech) Breakout; Good Sign For Broad Market
Abe Jouejati 3/1/2017 4:46:32 PM

My Simple Forecast:

Looks like $XBI has had a positive growth trend. With middle of the year approaching I believe that the cycle will repeat, thus hitting high points again. The seasonal patterns may be based on the rate of discovery of new technology, so cycles may be of unusual lengths. Nonetheless, looks like $XBI is positively correlated to SP500, and it is leading variable. We can anticipate new highs by beginning Q3.

1 to 2 of 2 comments